Millennium Management’s Procept Biorobotics PRCT Stock Holding History

Millennium Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$500K	Buy	+20,000	New	+$564K	﹤0.01%	4769
2024 Q4	–	Sell	-70,000	Closed	-$5.61M	–	6354
2024 Q3	$5.61M	Buy	70,000 +40,000	+133%	+$2.84M	﹤0.01%	2736
2024 Q2	$1.83M	Buy	30,000 +10,000	+50%	+$595K	﹤0.01%	3605
2024 Q1	$988K	Buy	+20,000	New	+$952K	﹤0.01%	4300
2023 Q4	–	Sell	-20,200	Closed	-$663K	–	6439
2023 Q3	$663K	Sell	20,200 -9,800	-33%	-$334K	﹤0.01%	4479
2023 Q2	$1.06M	Buy	+30,000	New	+$992K	﹤0.01%	3997
2022 Q3	–	Sell	-75,000	Closed	-$2.45M	–	7399
2022 Q2	$2.45M	Buy	+75,000	New	+$2.73M	﹤0.01%	3489

Other funds holding PRCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management's PRCT Position: Q1 2026 in Review

Millennium Management increased its Procept Biorobotics (PRCT) stake by 162% in Q1 2026, buying an estimated $17.5M and bringing the position to 1,005,458 shares worth $25.1M. The position accounts for 0.01% of the portfolio, ranked #1355.

Millennium Management first reported a position in PRCT in Q3 2021 and has held it in 15 quarters since. The position peaked at $31.6M in Q1 2025. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

Millennium Management held 1,005,458 shares of Procept Biorobotics worth $25.1M as of Q1 2026.
Millennium Management bought 622,321 Procept Biorobotics shares in Q1 2026, an estimated $17.5M.
Procept Biorobotics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1355 holding.
Millennium Management first reported a position in Procept Biorobotics in Q3 2021 and has held it in 15 quarters since.
Millennium Management's Procept Biorobotics position peaked at $31.6M in Q1 2025.
256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.